查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587486

北美非處方保健品市場規模、佔有率和趨勢分析：2025-2030 年按應用、形式、產品、人口、配銷通路和細分市場進行的預測

North America OTC Health Products Market Size, Share & Trends Analysis By Application (Digestive Health, Women's Health), By Form (Liquid, Gummies), By Product, By Demography, By Distribution Channel, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

北美非處方保健品市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，2030年北美OTC保健品市場規模預計將達到1066.1億美元，2025年至2030年複合年成長率為6.15%。

消費者對營養食品的認知和消費意願的提高、與文明病（包括肥胖和糖尿病）患病率的上升、可支配收入的增加以及非處方藥產品配銷通路的增加將推動成長。消費者越來越意識到營養食品的好處，可以幫助他們維持健康的生活方式，對市場成長產生正面影響。根據美國國立美國每年在減重營養食品（通常是錠劑）上美國約 21 億美元。

電子商務的出現增加了獲得營養食品的機會。除線上管道外，主要零售商包括 General Nutrition Centers, Inc.、沃爾瑪和 Vitamin Shoppe。因此，這些產品的容易獲得為該領域的主要參與者提供了成長機會。此外，消費者對 CBD 的偏好的改變預計將推動 CBD 產品的成長潛力，因為 CBD 具有舒緩作用，幾乎沒有精神作用。根據蓋洛普 2019 年的報告，大約 14% 的美國使用過某種形式的 CBD 注入產品。大約 58% 的成年人使用它來治療疼痛相關症狀，大約 42% 的成年人使用它來治療心理健康相關症狀。

COVID-19 大流行急劇增加了消費者對增強免疫力補充品的偏好。由於政府為遏制疫情而採取的限制措施，運動營養品、男女保健食品等行業受到了負面影響。自 2020 年第三季以來，COVID-19 的影響有所減弱，有助於市場復甦。

由於大量公司的存在，市場變得分散，導致競爭公司之間的敵對關係加劇。每家公司都建立了多個聯盟和併購，擴大了其產品組合併擴大了在全國各地的足跡。此外，公司還注重產品差異化和捆綁策略，以獲取更大的市場佔有率。例如，CV Sciences 於 2022 年 3 月推出了 PlusCBD Relief 軟膠囊。該公司聲稱它可以提供比原始配方好 7 倍的大麻二酚酸 (CBDA) 和大麻二酚 (CBD)。本品對治療發炎反應具有臨床意義。

北美非處方保健品市場報告重點：

  • 2024年，營養食品和減重產品細分市場佔比為33.71%。這是由於消費者對健康飲食益處的認知不斷增強、自我健康意識增強以及肥胖盛行率上升。
  • 由於人們對健身的認知不斷提高以及運動營養品的高商業性可用性，運動配方細分市場在 2024 年將佔據最大佔有率，達到 22.24%。
  • 由於成人市場有各種各樣的非處方藥產品，預計成人市場在預測期內將出現最快的成長。
  • 2024年，大賣場、超級市場和便利商店將主導市場。
  • 2024年，膠囊和錠劑佔據市場主導地位。這是由於市場上膠囊和錠劑形式的產品廣泛存在，不斷增加的技術創新以增強膠囊和錠劑的遞送形式，以及更長的保存期限。
  • 美國在收益方面佔據市場主導地位，主要是由於主要企業的存在、慢性病和肥胖症盛行率的增加以及人口迅速成長的老齡化。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章北美非處方保健品市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 北美OTC保健品市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 北美OTC保健品市場：產品預估及趨勢分析

  • 細分儀表板
  • 北美OTC保健品市場：產品變異分析
  • 北美非處方保健品市場：按產品分類的展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 預防咳嗽、感冒和流感的產品
    • 液體
    • 膠囊/錠劑
    • 軟糖
    • 其他
  • 營養食品和減重產品
    • 液體
    • 膠囊/錠劑
    • 軟糖
    • 其他
  • 運動營養產品
    • 液體
    • 膠囊/錠劑
    • 軟糖
    • 其他
  • 益生菌
    • 液體
    • 膠囊/錠劑
    • 軟糖
    • 其他
  • CBD食品補充劑
    • 液體
    • 膠囊/錠劑
    • 軟糖
    • 其他

第5章 北美OTC保健品市場：業態預估及趨勢分析

  • 細分儀表板
  • 北美OTC保健品市場：業態變化分析
  • 北美非處方保健品市場按業態展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 液體
  • 膠囊/錠劑
  • 軟糖
  • 其他

第6章 北美OTC保健品市場：應用預估及趨勢分析

  • 細分儀表板
  • 北美OTC保健品市場：應用變化分析
  • 北美非處方保健品市場，依應用前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 消化器官系統健康
  • 女性和男性的健康
  • 體重管理
  • 關節健康
  • 免疫防禦
  • 運動配方
  • 其他

第7章 北美OTC保健品市場：人口統計估計及趨勢分析

  • 細分儀表板
  • 北美非處方保健品市場：人口統計分析
  • 按人口統計的北美非處方藥保健品市場展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 孩子
  • 成人

第8章北美OTC保健品市場：通路估算及趨勢分析

  • 細分儀表板
  • 北美OTC保健品市場：通路變化分析
  • 北美非處方保健品市場：按分銷管道分類的展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 零售藥房
  • 線上
  • 大型超級市場、超級市場、便利商店
  • 其他

第9章北美非處方保健品市場：區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第10章競爭格局

  • 市場參與企業分類
  • 主要市場參與企業的最新趨勢和影響分析
  • 2024 年企業市場佔有率分析
  • 主要企業簡介
    • Herbalife Nutrition
    • CV Sciences, Inc.
    • Medical Marijuana Inc.
    • Nature's Sunshine Products Inc.
    • Johnson and Johnson Services, LLC
    • GlaxoSmithKline Inc.
    • Bayer AG
    • American Health
    • THE BOUNTIFUL COMPANY（Nestle Health Science SA）
Product Code: GVR-4-68039-951-7

North America OTC Health Products Market Growth & Trends:

The North America OTC health products market size is expected to reach USD 106.61 billion by 2030, expanding at a CAGR of 6.15% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising consumer awareness and increasing consumer willingness to spend on nutritional supplements, the increasing prevalence of lifestyle diseases including obesity & diabetes, rise in disposable income, and an increase in the number of distribution channels for OTC products are some of the key factors driving growth. Consumers are increasingly realizing the benefits of nutritional supplements, which help them sustain a healthy lifestyle, thereby positively impacting the market growth. According to the National Institute of Health, Americans spend around USD 2.1 billion annually on weight-loss dietary supplements, usually in the form of pills.

The emergence of e-commerce has led to increased accessibility to dietary and nutritional supplements. Apart from the online channels, companies such as General Nutrition Centers, Inc.; Walmart; and Vitamin Shoppe are some of the major retail outlets. Thus, the easy availability of these products will provide growth opportunities to key players in this space. Moreover, shifting consumer preference to CBD due to its healing properties and limited to no psychoactive effects is expected to drive the growth potential for CBD-infused products. According to Gallup, Inc. report of 2019, approximately 14% of individuals in the U.S. have used some or the other form of CBD-infused products. About 58% of adults use it for pain-related conditions and around 42% for mental health-related conditions.

The COVID-19 pandemic resulted in a surge in consumer preference for immunity-boosting supplements. Segments such as sports nutrition, and women's & men's health saw a negative impact due to lockdowns imposed by governments to curb the pandemic. The effect of COVID-19 declined post the third quarter of 2020, which helped the market regain traction.

The market is fragmented with the presence of a large number of companies, intensifying the overall competitive rivalry. Companies are undertaking multiple partnerships and mergers & acquisitions to increase their portfolio & expand their footprint across the country. In addition, companies are focusing on product differentiation and bundling strategies to capture a greater market share. For instance, in March 2022, CV Sciences, Inc. launched PlusCBD Relief Softgels. The company claims that it can deliver seven times better Cannabidiol Acid (CBDA) and Cannabidiol (CBD) than its raw formula. This product has clinical significance in the treatment of inflammatory responses.

North America OTC Health Products Market Report Highlights:

  • The dietary supplements and weight loss products segment accounted for 33.71% of the share in 2024. This is attributed to an increase in consumer awareness about the benefits of a healthy diet, growing self-health consciousness, and a rise in the prevalence of obesity
  • The sports formulation segment accounted for the largest share of 22.24% in 2024 due to rising awareness about fitness and high commercial availability of sports nutrition
  • Adults segment is projected to witness the fastest growth during the forecast period owing to the availability of a wide variety of OTC products for the adult demographic
  • Hypermarkets, supermarkets, and convenience stores dominated the market in 2024, owing to the better feasibility of buying from such places and an increase in the number of strategic initiatives like schemes such as loyalty programs
  • The capsules & tablets segment dominated the market in 2024. This can be attributed to the wide availability of products in capsule & tablet form in the market, the rise in innovation to enhance capsules & tablets delivery forms, and higher shelf-life
  • The U.S. dominated the market in terms of revenue, mainly due to the presence of key players, an increase in the prevalence of chronic diseases & obesity, and a rapidly growing geriatric population

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Form
    • 1.2.4. Demography
    • 1.2.5. Distribution Channel
    • 1.2.6. Country Scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Country outlook
  • 2.4. Competitive Insights

Chapter 3. North America OTC Health Products Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Consumer Demand for Self-Care
      • 3.2.1.2. Expansion of Product Offerings
      • 3.2.1.3. Aging Population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory Challenges
      • 3.2.2.2. Competition from Prescription Drugs
  • 3.3. North America OTC Health Products Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. North America OTC Health Products Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America OTC Health Products Market: Product Movement Analysis
  • 4.3. North America OTC Health Products Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Cough, Cold, and Flu Products
    • 4.5.1. Liquid
      • 4.5.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Capsules/Tablets
      • 4.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Gummies
      • 4.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Dietary Supplements and Weight Loss Products
    • 4.6.1. Liquid
      • 4.6.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Capsules/Tablets
      • 4.6.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Gummies
      • 4.6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Sports Nutrition Products
    • 4.7.1. Liquid
      • 4.7.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.2. Capsules/Tablets
      • 4.7.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.3. Gummies
      • 4.7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.4. Others
      • 4.7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Probiotics
    • 4.8.1. Liquid
      • 4.8.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.2. Capsules/Tablets
      • 4.8.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.3. Gummies
      • 4.8.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.4. Others
      • 4.8.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. CBD Nutraceutical Products
    • 4.9.1. Liquid
      • 4.9.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.2. Capsules/Tablets
      • 4.9.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.3. Gummies
      • 4.9.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.4. Others
      • 4.9.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America OTC Health Products Market: Form Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America OTC Health Products Market: Form Movement Analysis
  • 5.3. North America OTC Health Products Market by Form Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Liquid
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Capsules/Tablets
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Gummies
    • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America OTC Health Products Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. North America OTC Health Products Market: Application Movement Analysis
  • 6.3. North America OTC Health Products Market by Application Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Digestive health
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Women's & Men's Health
    • 6.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Weight Control
    • 6.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Joint health
    • 6.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Immune Defense
    • 6.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Sports Formulation
    • 6.10.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11. Others
    • 6.11.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. North America OTC Health Products Market: Demography Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. North America OTC Health Products Market: Demography Movement Analysis
  • 7.3. North America OTC Health Products Market by Demography Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Children
    • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Adults
    • 7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. North America OTC Health Products Market: Distribution Channel Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. North America OTC Health Products Market: Distribution Channel Movement Analysis
  • 8.3. North America OTC Health Products Market by Distribution Channel Outlook (USD Million)
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5. Retail pharmacies
    • 8.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Online
    • 8.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Hypermarkets, supermarkets, convenience stores
    • 8.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Others
    • 8.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. North America OTC Health Products Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.3. North America
    • 9.3.1. U.S.
      • 9.3.1.1. Key country dynamics
      • 9.3.1.2. Regulatory framework/ reimbursement structure
      • 9.3.1.3. Competitive scenario
      • 9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.2. Canada
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework/ reimbursement structure
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.3. Mexico
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework/ reimbursement structure
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Recent Developments & Impact Analysis by Key Market Participants
  • 10.3. Company Market Share Analysis, 2024
  • 10.4. Key Company Profiles
    • 10.4.1. Herbalife Nutrition
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. CV Sciences, Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Medical Marijuana Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Nature's Sunshine Products Inc.
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Johnson and Johnson Services, LLC
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. GlaxoSmithKline Inc.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Bayer AG
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. American Health
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. THE BOUNTIFUL COMPANY (Nestle Health Science S.A.)
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. North America OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 4. North America OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 5. North America OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 6. North America OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 7. North America OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 8. U.S. OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 9. U.S. OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 10. U.S. OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 11. U.S. OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 12. U.S. OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 13. Canada OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 14. Canada OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 15. Canada OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 16. Canada OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 17. Canada OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 18. Mexico OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 19. Mexico OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 20. Mexico OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 21. Mexico OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 22. Mexico OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research approaches
  • Fig. 2 Value chain-based sizing & forecasting
  • Fig. 3 Market formulation & validation
  • Fig. 4 North America OTC Health Products market segmentation
  • Fig. 5 Market driver analysis (current & future impact)
  • Fig. 6 Market restraint analysis (current & future impact)
  • Fig. 7 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 8 Porter's five forces analysis
  • Fig. 9 North America OTC health products market: Product outlook and key takeaways
  • Fig. 10 North America OTC health products market: Product movement analysis
  • Fig. 11 Cough, cold, and flu products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 12 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 13 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 14 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 15 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 16 Dietary supplements and weight loss products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 17 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 18 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 19 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Sports nutrition products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 Probiotics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 CBD nutraceutical products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 North America OTC health products market: Application outlook and key takeaways
  • Fig. 37 North America OTC health products market: Application movement analysis
  • Fig. 38 Digestive health market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 39 Women's & men's health market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 40 Weight control market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Joint health market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 Immune defense market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 43 Sports formulation market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 North America OTC health products market: Form outlook and key takeaways
  • Fig. 46 North America OTC health products market: Form movement analysis
  • Fig. 47 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 Capsules & tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 Gummy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 50 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 51 North America OTC health products market: Distribution channel outlook and key takeaways
  • Fig. 52 North America OTC health products market: Distribution channel movement analysis
  • Fig. 53 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 54 Online market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 55 Hypermarkets, supermarkets, convenience stores market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 North America OTC health products market: Demography outlook and key takeaways
  • Fig. 58 North America OTC health products market: Demography movement analysis
  • Fig. 59 Children market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 Adults market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 North America market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 62 US market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 63 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 64 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 65 List of key emerging company's/disruptors/innovators